stemcellindex.com
| ASTM | $0.36 | -0.01 | -2.14% | 609,769 | 43% | $57.2M | 140% | -54% | 1 Alert (0 News) - View | |
| CUR | $1.19 | -0.01 | -0.83% | 117,385 | 217% | $40.1M | 59% | -47% | 1 Alert (0 News) - View | |
| CYTX | $4.37 | -0.17 | -3.74% | 634,194 | 102% | $128.0M | 208% | -49% | No Alerts/News | |
| GERN | $6.83 | -0.15 | -2.15% | 1,225,440 | 47% | $608.2M | 250% | -20% | 1 Alert (0 News) - View | |
| KOOL | $0.73 | 0.13 | 21.67% | 2,042,891 | 584% | $40.9M | 135% | -62% | 1 Alert (0 News) - View | |
| OPXA | $0.53 | -0.10 | -15.94% | 244,638 | 318% | $6.4M | 488% | -81% | 1 Alert (0 News) - View | |
| OSIR | $14.11 | 0.12 | 0.86% | 429,808 | 227% | $461.5M | 31% | -35% | No Alerts/News | |
| PSTI | $1.27 | -0.03 | -2.31% | 26,047 | 54% | $14.9M | 388% | -45% | 1 Alert (0 News) - View | |
| STEM | $1.75 | -0.03 | -1.69% | 1,870,985 | 82% | $180.5M | 165% | -43% | ||
Stem Cell stocks are showing bullish stregth on the momentum of President Obama passing the new stem cell law
Digg
| 
Reddit
| 
Mixx
| 
del.icio.us
| 
Stumble it! | 
| Share it
|
Comments submitted from other visitors |
More posts, Page # :
Cell Therapeutics, Inc Stem Cell Companies Stem Cell Stocks BioMimetic Therapeutics (BMTI) Pluristem Therapeutics-PTSI Osiris Therapeutics-OSIR Cytori Therapeutics, Inc. ThermoGenesis (KOOL) Nutra Pharma (OTCBB:NPHC) Human Embryonic Stem Cell Market RTI Biologics (RTIX) Aastrom Biosciences -ASTM XOMA 052 Designated Orphan Drug by FDA ...
Published:Wed, 04 Aug 2010 05:00:00 -0700
BERKELEY, Calif. -- XOMA Ltd. , a leader in the discovery and development of therapeutic antibodies, announced that the U.S. Food and Drug Administration has designated XOMA 052, ......
Published:Wed, 04 Aug 2010 05:00:00 -0700
BERKELEY, Calif. -- XOMA Ltd. , a leader in the discovery and development of therapeutic antibodies, announced that the U.S. Food and Drug Administration has designated XOMA 052, ......
XOMA to Announce 2010 Second Quarter Fi...
Published:Mon, 02 Aug 2010 05:00:00 -0700
BERKELEY, Calif. -- XOMA Ltd. , a leader in the discovery and development of antibody therapeutics, announced that the company will host a webcast conference call on Monday, Augus......
Published:Mon, 02 Aug 2010 05:00:00 -0700
BERKELEY, Calif. -- XOMA Ltd. , a leader in the discovery and development of antibody therapeutics, announced that the company will host a webcast conference call on Monday, Augus......
XOMA 052 Orphan Drug Designation for Be...
Published:Thu, 29 Jul 2010 05:00:00 -0700
BERKELEY, Calif. -- XOMA Ltd. , a leader in the discovery and development of therapeutic antibodies, announced that the Committee for Orphan Medical Products of the European Medic......
Published:Thu, 29 Jul 2010 05:00:00 -0700
BERKELEY, Calif. -- XOMA Ltd. , a leader in the discovery and development of therapeutic antibodies, announced that the Committee for Orphan Medical Products of the European Medic......
Biotech Stocks: Depomed, Dendreon lead ...
Published:Wed, 04 Aug 2010 07:55:59 -0700
Depomed lead gains among drug stocks a day after it said Pfizer will not file a patent infringement lawsuit to prevent the launch of a painkiller.......
Published:Wed, 04 Aug 2010 07:55:59 -0700
Depomed lead gains among drug stocks a day after it said Pfizer will not file a patent infringement lawsuit to prevent the launch of a painkiller.......
Trader Favorite Dendreon Spikes On Prov...
Published:Wed, 04 Aug 2010 08:00:00 -0700
After soaring higher on the FDA approval of its Provenge prostate cancer vaccine in April, volatile Dendreon quickly retreated to well below its pre-approval pricing, but sales fi......
Published:Wed, 04 Aug 2010 08:00:00 -0700
After soaring higher on the FDA approval of its Provenge prostate cancer vaccine in April, volatile Dendreon quickly retreated to well below its pre-approval pricing, but sales fi......
